Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1986;89(3):317-22.
doi: 10.1007/BF00174367.

The discriminative stimulus properties of zolpidem, a novel imidazopyridine hypnotic

Comparative Study

The discriminative stimulus properties of zolpidem, a novel imidazopyridine hypnotic

D J Sanger et al. Psychopharmacology (Berl). 1986.

Abstract

Zolpidem is a non-benzodiazepine hypnotic drug which displaces benzodiazepines from their binding sites in different brain structures. Previous work has demonstrated several differences between zolpidem and benzodiazepines, including differences between the stimulus properties of zolpidem and chlordiazepoxide. In the present study the discriminative stimulus properties of zolpidem were analysed by training rats to discriminate between this drug and saline. It was found that stimulus control developed readily with 2 mg/kg but not with 1 mg/kg zolpidem. The effect was dose-related, had a short duration of action and was antagonised by Ro 15-1788. Furthermore, stimulus control produced by zolpidem was associated with marked reductions in rates of responding. Injections of chlordiazepoxide, triazolam, lorazepam, zopiclone, CL 218,872 and pentobarbital produced dose-related responding on the zolpidem-associated lever but haloperidol did not. However, in general, the doses of those drugs which produced drug-lever responding also reduced response rates. It is possible that the above mentioned differences between the discriminative stimulus produced by zolpidem in rats and those produced by other sedatives may be due to a selective action of zolpidem on a sub-type of benzodiazepine binding site.

PubMed Disclaimer

References

    1. Psychopharmacology (Berl). 1985;87(2):233-7 - PubMed
    1. Prog Neuropsychopharmacol Biol Psychiatry. 1984;8(3):359-64 - PubMed
    1. Psychopharmacologia. 1966;10(1):6-31 - PubMed
    1. Pharmacol Biochem Behav. 1982 Oct;17(4):709-13 - PubMed
    1. Eur J Pharmacol. 1976 May;37(1):113-23 - PubMed

Publication types

LinkOut - more resources